Hopp til innhold

Get alerts of updates about «Who will get the coronavirus vaccine?»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Who will get the coronavirus vaccine?


Who will get the coronavirus vaccine?

Here you will find information about which groups are offered coronavirus vaccine and when we expect that the various groups will have received an offer.


Here you will find information about which groups are offered coronavirus vaccine and when we expect that the various groups will have received an offer.

These will be offered a coronavirus vaccine: 

Risk groups

By risk groups we mean people with an increased risk of a severe COVID-19 disease course. These include:

  • Residents in nursing homes

  • Everyone who is 65 years or older

  • People aged 12 years - 64 years with one or more defined diseases / conditions that increase the risk of a severe disease course and death from COVID-19. See the section below for specification of different diseases / conditions and age groups.

Other groups

  • Healthcare personnel and other employees in the health and care service who have close contact with patients during treatment or care.

  • Everyone over and including the age of 12 years.

Risk groups

People with the following disease/ conditions are defined as medical risk groups: 

  • Organ transplant*
  • Immunodeficiency*
  • Hematologic (blood) cancer in the last 5 years*
  • Other active cancer, ongoing or recently finished treatment for cancer (especially immunosuppressive therapy, radiation therapy to the lungs or chemotherapy)* 
  • Neurological or muscular disease with impaired coughing strength or lung function (e.g., ALS and cerebral palsy)*
  • Downs Syndrome*
  • Chronic kidney disease or significantly impaired renal function
  • Chronic liver disease or significantly impaired liver function 
  • Immunosuppressive therapy, e.g. with autoimmune diseases
  • Diabetes  
  • Chronic lung disease, including severe asthma that has required the use of high-dose inhaled steroids or steroid tablets during the last year
  • Obesity with body mass index (BMI) of ≥ 35 kg/m2 or higher
  • Dementia 
  • Chronic cardiovascular disease (except high blood pressure)
  • Stroke

Other serious and / or chronic diseases may also increase the risk of a severe disease course.

* These diseases/ conditions can give a high risk for a severe disease course and death among younger people. 

For more detailed information about diseases/conditions that can give an increased risk for a severe COVID-19 disease course see: 

Getting the vaccine

The solutions used for appointments vary between municipalities. In some places, drop-in vaccination is available without the need for an appointment. Check your municipality's website for information about the local arrangements.

The vaccine is free.

People who belong to these groups and are resident or staying temporarily in Norway can have the vaccine as part of the immunisation programme. 

Rationale for the recommendations to the different groups

  • Adults and adolescents aged 16-64 years are recommended two doses of coronavirus vaccine. From 65 years and older, it is recommended to give a booster dose at least 6 months after the second dose. The recommendation is primarily related to the risk of a severe COVID-19 disease course in these groups. It is the oldest, and people with certain diseases and conditions who have the greatest risk of a severe disease course and death from COVID-19 disease. Although most young and healthy people recover well from COVID-19, some in this group may also become seriously ill.

  • A small group of people with severe immune deficiency are recommended to have 3 doses because they have insufficient protection after the first two doses. In these cases, the third dose should be given at least 4 weeks after the second dose.

  • Healthcare professionals who have contact with patients at particularly high risk of a severe disease course will also be offered a booster dose of coronavirus vaccine no earlier than 6 months after dose 2. 
  • Pregnancy: The risk of a severe COVID-19 disease course among pregnant women is low. However, pregnant women still have a slightly higher probability of a severe disease course than non-pregnant women. The risk is highest in the last stage of pregnancy. The coronavirus vaccine is therefore recommended for pregnant women who are in their 2nd and 3rd trimester. Pregnant women with other underlying conditions (belonging to risk groups) can also be vaccinated in the 1st trimester. This is because the risk of a severe disease course will also be higher in the 1st trimester among those with underlying conditions.

  • Adolescents 12-15 years: All adolescents in this age group are offered one dose of coronavirus vaccine. This group rarely becomes seriously ill with COVID-19 disease. The direct medical benefit of the vaccine for the individual adolescent is less clear than for the older age groups who have a higher risk of serious illness. Some children and adolescents could still have a severe disease course. The offer of vaccination means that the individual has the opportunity to protect themselves through vaccination.
    Children and adolescents with severe underlying diseases have a higher risk of severe COVID-19 disease course and coronavirus vaccine is recommended. They should have two doses.

  • Vaccination in all these groups will, in addition to protecting those who are vaccinated, also help to reduce transmission in society.

For further information about severe COVID-19 disease course for risk groups see:

Read more about recommendations for adolescents aged 12-15:

Pregnancy and breastfeeding

After recovery from COVID-19


10.11.2021: Updated section about the rationale for the vaccine - booster doses, third doses and pregnancy

04.09.2021: Added text about the offer of coronavirus vaccine for adolescents 12-15 years. Removed text about priority groups, since there is now good access to vaccine. Otherwise some minor adjustments and text editing that do not entail any change in existing advice and recommendations.

18.08.2021: Updated with information regarding vaccination of 16-17-year-olds

29.07.2021: Adolescents 12-17 years - removed sentence: These can then be offered the BioNTech and Pfizer vaccine, which is approved for use from the age of 12 years.

02.07.2021: Removed paragraph about pregnancy and breastfeeding and added link to a page with further advice

02.07.2021: Young and healthy people will also benefit from the vaccine. Although most people cope well with COVID-19, there are some in this group who could also become seriously ill.

22.06.2021: Added sentence about 2003 cohort being offered the vaccine from BioNTech/Pfizer

04.06.2021: Changed ages from 16-17 years til 12-17 years

02.06.2021: Updated paragraph about vaccination of children.

02.06.2021: Updated link to vaccination of health care workers

27.05.2021: Added sentences about lower age groups and people with problematic substance abuse

21.05.2021: Added groups 10 and 11

20.05.2021: Removed "It has not yet been decided how the coronavirus vaccine will be offered to healthy people aged 18-44."

05.05.2021: Removed sentence "as long as they feel well and do not have lasting effects from the disease at the time of vaccination"

03.05.2021: Under the list of risk groups, Down's syndrome has been highlighted as a separate priority group.

29.04.2021: Changed advice about vaccination of pregnant women so that it can be considered if the benefits outweigh the disadvantages. Breastfeeding women can be vaccinated.

19.03.2021: Removed cystic fibrosis as example under chronic lung diseases

12.03.2021: Added vaccination scenario in English

10.03.2021: Added cerebral palsy to list of neurological or musculoskeletal diseases. Updated section about recovery from COVID-19

09.03.2021: Added sentence about age cohorts, that everyone born in the same year will be vaccinated at the same time.

01.03.2021: Updates to section about prioritisation of healthcare personnel.

18.02.2021: Ungdom 16-18 - added referral to risk group list. Updated priority list - updated paragraph about prioritisation of healthcare personnel.

15.02.2021: Added sentence: "It has not yet been decided how the coronavirus vaccine will be offered to healthy people aged 18-44 years outside the prioritised groups."

04.02.2021: Removed paragraph about children in risk groups. Emphasised that two groups (65-74 years and people 18-64 years with condition marked with *) in point 4 shall be offered the vaccine at the same time. New text about 16-17 year-olds with severe and complex diseases and congenital syndromes with high risk can be considered for vaccination. Link to risk groups.

08.01.2021: New setup with one priority list for COVID-19 vaccination and one for medical risk groups. New definition of asthma: severe asthma that has resulted in the use of high-dose inhaled steroids or steroid tablets in the past year. New link to risk groups. Updated advice for pregnant and breastfeeding women.

05.01.2021: added sentence about people who are resident in Norway being taking the vaccine.

04.01.2021: added "selected groups of healthcare personnel to order of priority"

31.12.2020: Added section about vaccination after recovery from COVID-19